[HTML][HTML] Immunosuppression and liver transplantation
J Lerut, S Iesari - Engineering, 2023 - Elsevier
Perfect surgical techniques and adequate immunosuppression are key to ensuring optimal
graft and patient survival. The availability of different drugs has led to several, often industry …
graft and patient survival. The availability of different drugs has led to several, often industry …
Immunosuppression in liver and intestinal transplantation
JP Lerut, GE Gondolesi - Best Practice & Research Clinical …, 2021 - Elsevier
Immunosuppression handling plays a key role in the early and long-term results of
transplantation. The development of multiple immunosuppressive drugs led to numerous …
transplantation. The development of multiple immunosuppressive drugs led to numerous …
[HTML][HTML] Tacrolimus analogue produced by Bacillus amyloliquefaciens HSSN09 suppresses watermelon Fusarium wilt by antagonizing FON
BY Yang, JX Yang, G Wang, WP Dong, PL Xu, Y Zheng… - Biological Control, 2024 - Elsevier
Watermelon Fusarium wilt caused by Fusarium oxysporum f. sp. niveum (FON) is one of the
most devastating diseases in watermelon production. Biological control approaches are …
most devastating diseases in watermelon production. Biological control approaches are …
Basiliximab induction versus no induction in adult heart transplantation
KN Rudzik, RM Rivosecchi, BA Palmer… - Clinical …, 2023 - Wiley Online Library
Background Induction immunosuppression in heart transplant recipients varies greatly by
center. Basiliximab (BAS) is the most commonly used induction immunosuppressant but has …
center. Basiliximab (BAS) is the most commonly used induction immunosuppressant but has …
Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk–a …
H Ali, M Mohammed, T Fülöp, S Malik - Annals of Medicine, 2023 - Taylor & Francis
Introduction The aim of this study is to assess the outcomes of different induction therapies
among mild to moderate immunological risk kidney transplants in the era tacrolimus and …
among mild to moderate immunological risk kidney transplants in the era tacrolimus and …
[PDF][PDF] Current Induction Therapy Strategies and Anti-T Lymphocyte Globulin Usage in Kidney Transplantation: Consensus-Based Recommendations by a Turkish …
Ü Çakır, A Dinçkan, N Karadoğan, K Keven… - Turkish Journal of …, 2024 - turkjnephrol.org
This advisory committee convened to review national and global kidney transplantation
dynamics and provide recommendations on the use of anti-T lymphocyte globulin (ATLG) for …
dynamics and provide recommendations on the use of anti-T lymphocyte globulin (ATLG) for …
[PDF][PDF] Transplant Risk Assessment: It Is Not about the Panel Reactive Antibodies
Dear Editor, We have read with great interest the article written by Ali et al.[1]
titled:“Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk …
titled:“Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk …
Induction Therapy, HLA Mismatching, and Standard-Risk Kidney Transplantation
Dear Editor, We have read with great interest the research work titled “Outcomes of
Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant …
Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant …